Results 231 to 240 of about 482,321 (300)

Rationale of New Grading System: Central Compartment Atopic Disease

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Central compartment atopic disease (CCAD) has recently been recognized as a distinct phenotype within the spectrum of type 2–dominant chronic rhinosinusitis (CRS). Although international guidelines highlight polypoid changes in the central nasal cavity, standardized diagnostic and classification criteria are still lacking.
Ramón Moreno‐Luna, Carmen Palma‐Martínez, Serafin Sánchez‐Gómez, Isam Alobid, Daniel Martin‐Jimenez, José Miguel Villacampa‐Aubá, Christian Calvo‐Henríquez, Alfonso Del Cuvillo, Alfonso Santamaría‐Gadea, Jaime González‐García, Richard J. Harvey, John M. DelGaudio   +11 more
wiley   +1 more source

Infant social withdrawal and rapid infant weight gain. [PDF]

Int J Obes (Lond)
Sander S, Stuart AC, Stougaard M, Sørensen TIA, Mohr JEW, Væver MS.   +5 more
europepmc   +1 more source

Clustering dichotomously scored items through functional data analysis

, 2016
DI BATTISTA, Tonio, FORTUNA, FRANCESCA
openaire   +2 more sources

External Quality Assessment as a strategy for Chagas disease surveillance: a study in four municipalities of Pernambuco. [PDF]

Rev Soc Bras Med Trop
Soares ENL, Rocha DDS, Seabra AP, Oliveira-Correia JPS, Moraes FVG, Silva RAE, Galvão C.   +6 more
europepmc   +1 more source

A meta-analysis of sexual orientation inequities in substance use among youth. [PDF]

Addiction
Mereish EH, Lee H, Goldbach JT, Hathaway S, Hennessy EA.   +4 more
europepmc   +1 more source

Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain. [PDF]

JAMA Intern Med
Slawek DE, Zhang C, Dahmer S, Sohler N, Zolotov Y, Starrels JL, Deng Y, Calderon DiFrancesca G, Levin FR, Ross J, Minami H, Cunningham CO, Arnsten JH.   +12 more
europepmc   +1 more source

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

JAMA Pediatr
Rasmussen MIS, Hansen ML, Pellicer A, Hyttel-Sørensen S, Ergenekon E, Szczapa T, Hagmann C, Naulaers G, Mintzer J, Fumagalli M, Dimitriou G, Dempsey E, Tkaczyk J, Fredly S, Heuchan AM, Pichler G, Fuchs H, Nesargi S, Hahn GH, Piris-Borregas S, Širc J, Alsina-Casanova M, Stocker M, Ozkan H, Sarafidis K, Kraus NJ, Karen T, Rzepecka-Weglarz B, Oguz SS, Thewissen L, Arruza L, Memisoglu AC, Del Rio Florentino R, Baserga M, Maton P, Schneider J, de Las Cuevas MI, Hedegaard SS, Zafra P, Bender L, Farquharson S, Ochoda-Mazur A, Lecart C, El-Khuffash A, Chathasaigh CN, Miletin J, Papathoma E, Vesoulis Z, Serrao F, SafeBoosC-III Follow-Up Writing Group for the SafeBoosC-III Follow-Up Collaborator Group , Cornette L, Yasa B, Klamer A, Barcos-Munoz F, Boetti T, Cetinkaya M, Montasser M, Hatzidaki E, Bokiniec R, Marciniak S, Chalak L, Rao SA, Sadowska-Krawczenko I, Serrano-Viñuales I, Krolak-Olejnik B, Plomgaard AM, Hansen BM, Olsen MH, Gluud C, Jakobsen JC, Greisen G.   +70 more
europepmc   +1 more source